Cortellis Generics & Products Intelligence

A single source of global drug, market, API, and patent data

Make timely and data-driven business decisions with a comprehensive, single source of market performance, patent and manufacturing data.

Have confidence you’re making the most informed IP, sourcing, portfolio and business development decisions using reliable and integrated data in a single, easily searchable solution. Strategically develop your portfolio, find API suppliers, gain insight on when drugs lose exclusivity and monitor your competition.

How we help

Pinpoint when a drug will go generic to expand your portfolio

Identify when a drug will lose exclusivity and identify new launch opportunities using expertly curated and searchable data compiled into a Constraint Date Forecast and Product Selector Tool.

Efficiently plan launches

Make data-driven decisions to inform your launch strategies, sales forecasts and commercial plans with easily accessible and digestible global sales, kg consumption, pack price and market share data all in a single, trusted solution.

Understand global biopharma pricing trends

Inform product selection or portfolio rationalization with a better understanding of market dynamics, dose form advantage and reimbursement trends provided by comparable currency and historical biopharma pricing data.

Why choose us

price_check

Pharma global pricing trends

Optional module to optimize biopharma pricing strategies, anticipate payer pressure, determine impact on market access and plan future launches.
Generic biopharma pricing and reimbursement intelligence of final dose formulations across 90+ markets.
Historical market share and generic pharma pricing data of up to 5 years for United States and Latin America markets.

calendar_month

Constraint Date Forecast

Easy-to-use, intuitive tool
Identifies earliest time a drug can enter the generic market.
Based on several data sources such as constraining patents, exclusivities and SPCs.
Includes one date for each country.

link

Product and company selectors

Easy-to-use, intuitive tool
Provide ability to quickly identify new launch opportunities based on specific criteria.
Connect ~50 product and company criteria around LOE, market potential and competitiveness.

notifications_active

Timely updates and alerts

Daily updates for US patent challenges.
Weekly updates for manufacturing and patent intelligence.
Monthly or quarterly updates for market performance.
Customizable email alerts for new or updated product or company data.

Want to learn more?

Speak to our team north_east

All-inclusive data in a single, integrated location

72k+

companies, including API and dose manufacturers

61k+

small molecules and biologics

26k+

supplementary protection certificates

1.1m+

worldwide patents, including patent families, SPCs and patent litigation

18k+

synthesis schemes

[Cortellis Product Intelligence] provides a wide range of information in one place, which is otherwise difficult to obtain. [It] saves substantial time and, at the same time, provides a thorough picture on the topics.

Head of Patents Pharmaceutical company

When we plan [our] generic portfolio to enter U.S. and E.U. markets, we survey information on Cortellis Product Intelligence.

IP Analyst Pharmaceutical company

This platform is a one-stop shop for commercial as well as competitive information. It saves considerable time, it’s easy to navigate, it’s easy to download and use information as desired, and hence, it’s a productive and progressive tool for an organization.

Business Development and Licensing Pharmaceutical company

[Cortellis Product Intelligence] is one the greatest tools for us to manage our suppliers in API business. [It] provides unique and serious data for those who are responsible in supply management, control and new product development.

Managing Director – Asia Pacific US-based pharmaceutical company

We have had [Cortellis Product Intelligence] for over 15 years. With competition at an all-time high, you need a place with direct information in one spot.

Business Development and Licensing Pharmaceutical company

Building and continually monitoring a differentiated product portfolio is critical for us, and Clarivate has helped us do just that, which is essential to our growth.

Chairman and CEO Pharmaceutical company

chevron_left

chevron_right

Resources

Webinar

Biosimilars in Oncology

The availability of of biologic therapies to treat oncology disease conditions has led to improved clinical outcomes, but the high cost can create barriers and disparities in treatment access and outcomes. The use of biosimilars can improve patients’ access to care by decreasing treatment costs and creating price competition between the originator product and biosimilar...

north_east